These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 15472417

  • 1. Memantine: pharmacological properties and clinical uses.
    Kumar S.
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [Abstract] [Full Text] [Related]

  • 2. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
    Tanović A, Alfaro V.
    Rev Neurol; 2004 Sep; 42(10):607-16. PubMed ID: 16703529
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ, Werkgroep Klinische GerontoFarmacologie.
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy.
    Hartmann S, Möbius HJ.
    Int Clin Psychopharmacol; 2003 Mar; 18(2):81-5. PubMed ID: 12598818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Efficacy of memantine in the treatment of Alzheimer's disease].
    Molinuevo Guix JL, Lladó Plarrumaní A.
    Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
    [Abstract] [Full Text] [Related]

  • 11. Memantine in the treatment of dementia.
    Maggiore C, Locatelli L, Grandi FC, Pizzolato G, Cochrane Neurological Network.
    Neuroepidemiology; 2007 Dec; 28(2):118-9. PubMed ID: 17409774
    [No Abstract] [Full Text] [Related]

  • 12. Neuropathologic changes in Alzheimer's disease: potential targets for treatment.
    Wenk GL.
    J Clin Psychiatry; 2006 Dec; 67 Suppl 3():3-7; quiz 23. PubMed ID: 16649845
    [Abstract] [Full Text] [Related]

  • 13. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN.
    J Clin Psychiatry; 2006 Dec; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Memantine in dementia: a review of the current evidence.
    Herrmann N, Li A, Lanctôt K.
    Expert Opin Pharmacother; 2011 Apr; 12(5):787-800. PubMed ID: 21385152
    [Abstract] [Full Text] [Related]

  • 16. [Memantine].
    Molinuevo JL.
    Neurologia; 2003 Jun; 18(5):255-61. PubMed ID: 12768511
    [Abstract] [Full Text] [Related]

  • 17. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [Abstract] [Full Text] [Related]

  • 18. Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
    Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S.
    Int J Geriatr Psychiatry; 2010 Apr; 25(4):419-26. PubMed ID: 19670390
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.